Brief: Enorama Pharma Q1 Operating Loss Widens To SEK 10 Million
22/05/2024 07:34
May 22 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q1 REVENUE LOSS SEK 10,000 VERSUS PROFIT SEK 0.7 MILLION
YEAR
AGO
* Q1 OPERATING LOSS SEK 10 MILLION VERSUS LOSS SEK 9.8
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5Lssxn
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO